A new study from Karolinska Institutet explores the connection between inflammatory bowel disease (IBD) and chronic kidney ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

About 90% of U.S. adults meet the criteria for a newly recognized syndrome that comes from a combination of heart disease, ...

Your kidneys play a vital role in filtering toxins and maintaining overall health Being aware of these lesser-known symptoms ...

A newly approved drug for type 2 diabetes and kidney disease, sotagliflozin, has shown remarkable benefits in reducing the ...

• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...

Investigators compared the outcomes of patients with type 2 diabetes who continued versus stopped metformin after progressing to stage 4 chronic kidney disease.

Deaths from heart failure have been climbing steadily since 2012. Drugs to treat the 2 main types of heart failure aren't ...

Luca was diagnosed with Chronic Kidney Disease. He was added to the waitlist for a deceased donor transplant seven months ago.

Less than 5% of hospitalized adults with type 2 diabetes received an SGLT2 inhibitor or GLP-1 before being discharged, ...

Under the direction of the Yogi government, devotees are being offered high-level health facilities during the Mahakumbh fair ...

Meet mild, reversible acute kidney injury (AKI) -- a sudden loss of kidney function that can go away within 24 hours or, if unchecked, can lead to chronic kidney failure, dialysis or transplant! It ...